Structures by: Hazazi E. S.
Total: 5
1-(3-Chloro-4-tolyl)-5-méthylthio-3a-phényl-3a,11-dihydro-4H-[1,2,4] oxadiazolo[5,4-d][1,5]benzodiazépine
C24H20Cl1N3O1S1
Acta Crystallographica Section E (2002) 58, 5 o548-o550
a=8.6890(4)Å b=18.8253(9)Å c=13.3728(7)Å
α=90.0° β=103.470(3)° γ=90.0°
C17H14Cl2N2S1
C17H14Cl2N2S1
Acta Crystallographica Section E (2003) 59, 5 o713-o715
a=9.29410(10)Å b=9.7513(2)Å c=17.8510(3)Å
α=90.0° β=90.0° γ=90.0°
Ethyl 5-[2-(2-aminophenylimino)-2-phenylethylidene]- 4-(4-chlorophenyl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate
C25H21ClN4O2S
Acta Crystallographica Section C (2002) 58, 9 o585-o588
a=9.98260(10)Å b=9.5040(2)Å c=25.0790(10)Å
α=90° β=90.667(5)° γ=90°
Ethyl 5-{2-[2-(methylamino)phenylimino]-2-phenylethylidene}- 4-(4-nitrophenyl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate
C26H23N5O4S
Acta Crystallographica Section C (2002) 58, 9 o585-o588
a=9.7619(2)Å b=10.7465(3)Å c=12.1924(2)Å
α=87.137(2)° β=83.151(2)° γ=75.4690(10)°
C26H23N5O4S
C26H23N5O4S
Acta Crystallographica Section C (2000) 56, 10 e457-e458
a=18.4896(3)Å b=14.4128(5)Å c=18.6685(6)Å
α=90.000(10)° β=97.977(3)° γ=90.000(10)°